Advancing a promising scientific discovery to a viable treatment option requires long-term coordinated efforts from leaders across the biomedical ecosystem. Leaders from patient-centered nonprofits play a unique role in these efforts: they...

Two potential vaccines moving to clinical trial stage in addition to WHO’s global SOLIDARITY trial WASHINGTON, March 26, 2020 — The Milken Institute COVID-19 Treatment and Vaccine Tracker has identified 16 new treatments in the pipeline...

For a number of years, the Milken Institute Center for Strategic Philanthropy has been among the voices advocating for philanthropists to expand the scale of their social investments by unlocking the resources being held in donor-advised...

Instead of stepping into spring and the rituals of emerging from winter's slumber, today we are faced with a crisis that's unlike anything most of us have seen in our lifetimes. Coronavirus has brought health systems around the world to the...

Publicly available resource monitors the development of therapies to treat and prevent disease WASHINGTON, March 18, 2020 — The Milken Institute is launching a resource to help the public and policymakers track progress in the development...

Statement from Milken Institute Chairman Michael Milken All of us at Milken Institute are working closely with leaders in industry, government, and medical research organizations to: mitigate the spread of COVID-19; expedite the discovery...

WASHINGTON, March 4, 2020 – Esther Krofah, a respected leader in biomedical research, development, and public policy, has been named executive director of FasterCures, the Milken Institute center devoted to accelerating access to life...